दवाओं की अंतःक्रिया
Deferoxamine + Lovotibeglogene autotemcel
गंभीरता: गंभीर
Deferoxamine and Lovotibeglogene autotemcel: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Iron chelators may impair marrow recovery and engraftment around mobilization and myeloablative conditioning for this gene therapy. Labeling advises stopping chelation beforehand.
इस इंटरैक्शन का सरल भाषा में अर्थ
Deferoxamine and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Possible interference with hematopoietic recovery; the precise mechanism is not established.
क्या करें
Discontinue iron chelators at least 7 days before mobilization and conditioning. Use phlebotomy if iron reduction is needed during this period, as clinically appropriate.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Deferoxamine और Lovotibeglogene autotemcel की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Deferoxamine के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Deferoxamine with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Deferoxamine and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Iron chelators may impair marrow recovery and engraftment around mobilization and myeloablative conditioning for this gene therapy. Labeling advises stopping chelation beforehand.
How serious is the interaction between Deferoxamine and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue iron chelators at least 7 days before mobilization and conditioning. Use phlebotomy if iron reduction is needed during this period, as clinically appropriate.
What other medicines interact with Deferoxamine?
MediHelp also lists interactions of Deferoxamine with, for example, Ascorbic acid, Betibeglogene autotemcel, Exagamglogene autotemcel. The full list is on the Deferoxamine page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
